Bio Solution Co.,Ltd. (KOSDAQ:086820)

Market Cap	198.30B
Revenue (ttm)	8.27B
Net Income (ttm)	-1.28B
Shares Out	23.89M
EPS (ttm)	-53.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,863
Average Volume	66,742
Open	8,000.00
Previous Close	8,070.00
Day's Range	7,700.00 - 8,060.00
52-Week Range	3,903.33 - 13,200.00
Beta	0.66
RSI	46.33
Earnings Date	n/a

About MorphoSys AG

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 71
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086820